Olanzapine-Induced Neuroleptic Malignant Syndrome with Hypernatremia

被引：0
|
作者：
Tutuncu, Recep [1 ]
Gunay, Huseyin [1 ]
Balibey, Hakan [1 ]
机构：
[1] Etimesgut Mil Hosp, Ankara, Turkey
来源：
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 22卷 / 02期
关键词：
Olanzapine; neuroleptic malignant syndrome; hypernatremia; RHABDOMYOLYSIS;
D O I：
10.5455/bcp.20120419122843
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Neuroleptic Malignant syndrome (NMS) is a rare but potentially fatal adverse effect of antipsychotics. In addition, hypernatremia may play a significant role before occurrence of NMS or it may develop secondary to acute renal failure. Herein we report the case of a 27 year old male patient who developed NMS with hypernatremia and acute renal failure following treatment with olanzapine.
引用
收藏
页码：184 / 186
页数：3
相关论文
共 50 条
  • [41] Possible neuroleptic malignant syndrome associated with olanzapine
    Nyfort-Hansen, K
    Alderman, CP
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) : 667 - 667
  • [42] Olanzapine-associated neuroleptic malignant syndrome
    Kontaxakis, VP
    Havaki-Kontaxaki, BJ
    Christodoulou, NG
    Paplos, KG
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (05): : 897 - 902
  • [43] Olanzapine-associated neuroleptic malignant syndrome
    Norgard, Nick B.
    Stark, Jennifer E.
    PHARMACOTHERAPY, 2006, 26 (08): : 1180 - 1182
  • [44] Clozapine effective in olanzapine-induced Pisa syndrome
    Arora, Manu
    Praharaj, Samir Kumar
    Sarkar, Sukanto
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) : 2273 - 2275
  • [45] Olanzapine-induced manic-like syndrome
    Lindenmayer, JP
    Klebanov, R
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (06) : 318 - 319
  • [46] A case report of olanzapine-induced hypersensitivity syndrome
    Raz, A
    Bergman, R
    Eilam, O
    Yungerman, T
    Hayek, T
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2001, 321 (02): : 156 - 158
  • [47] Atypical neuroleptic malignant syndrome caused by olanzapine - comment
    Abad, JMH
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (03) : 240 - 240
  • [48] Neuroleptic malignant syndrome and low-dose olanzapine
    Suh, H
    Bronson, B
    Martin, R
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (04): : 796 - 796
  • [49] Life threatening neuroleptic malignant syndrome due to olanzapine
    Kopf, A
    Köster, J
    Schulz, A
    Krömker, H
    Becker, T
    PSYCHIATRISCHE PRAXIS, 2003, 30 (05) : 279 - 282
  • [50] Olanzapine/risperidoneAtypical neuroleptic malignant syndrome: case report
    Reactions Weekly, 2019, 1755 (1) : 246 - 246
12345